Discovery & Development

We find out the story behind the Baylor College of Medicine Center for Space Medicine.

Sanofi and DNDi are co-developing a drug – acoziborole – to treat sleeping sickness.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

What biosecurity risks do exo-microorganisms pose?

Ross Burn presents the story behind his career, including setting up a company on process chemistry and his views on industry 4.0.

Implementing green practices in clinical trials.

Oligonucleotide-based therapeutics present manufacturers with specific processing and characterization challenges.

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Novo Nordisk's Stephen Gough explains how pharma can address the cardiovascular risks associated with type 2 diabetes.

How can we effectively manage the treatment of type 1 diabetes?